| human | Q5 |
| P496 | ORCID iD | 0000-0001-5593-5098 |
| P108 | employer | Washington University School of Medicine | Q7972509 |
| P734 | family name | Rich | Q16882049 |
| Rich | Q16882049 | ||
| Rich | Q16882049 | ||
| P735 | given name | Keith | Q1159033 |
| Keith | Q1159033 | ||
| P106 | occupation | researcher | Q1650915 |
| Q35782988 | A CDC20-APC/SOX2 Signaling Axis Regulates Human Glioblastoma Stem-like Cells |
| Q37602542 | Biopsy of the superficial cortex: predictors of effectiveness and outcomes |
| Q37409721 | Codeletions at 1p and 19q predict a lower risk of pseudoprogression in oligodendrogliomas and mixed oligoastrocytomas |
| Q34167819 | Combined high-field intraoperative magnetic resonance imaging and endoscopy increase extent of resection and progression-free survival for pituitary adenomas |
| Q91280037 | Heterogeneity Diffusion Imaging of gliomas: Initial experience and validation |
| Q38338095 | Impact of 1p/19q codeletion and histology on outcomes of anaplastic gliomas treated with radiation therapy and temozolomide |
| Q55463753 | Implementation and Preliminary Clinical Experience with the Use of Ceiling Mounted Mobile High Field Intraoperative Magnetic Resonance Imaging Between Two Operating Rooms |
| Q48714163 | Management of atypical cranial meningiomas, part 1: predictors of recurrence and the role of adjuvant radiation after gross total resection |
| Q52145213 | Radiation Therapy for Residual or Recurrent Atypical Meningioma: The Effects of Modality, Timing, and Tumor Pathology on Long-Term Outcomes. |
| Q38254503 | Radiation therapy dose escalation for glioblastoma multiforme in the era of temozolomide |
| Q57464932 | Withholding Perioperative Steroids in Patients Undergoing Transsphenoidal Resection for Pituitary Disease: Randomized Prospective Clinical Trial to Assess Safety |
Search more.